A Study of KL340399 in Patients With Advanced Solid Tumors

NCT05387928 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: KL340399 injection

Sponsor

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.